Purchases and Sales Made in Q1 2022 in Viracta Therapeutics, Inc. (VIRX)
This table provides information about the institutional ownership of Viracta Therapeutics, Inc. (VIRX) during Q1 2022. The information is specifically focused on institutions that hold shares of Viracta Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-41.6K- 21.62% |
$92.7K - $198K
|
151K
$4.52K
|
|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-56K- 2.36% |
$125K - $267K
|
2.31M
$69.4K
|
|
|
May 13, 2022
Q1 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-67.7K- 58.51% |
$151K - $322K
|
48K
$1.44K
|
|
|
May 16, 2022
Q1 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-81.1KClosed |
$181K - $386K
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-135K- 98.38% |
$302K - $644K
|
2.23K
$66.8
|
|
|
May 16, 2022
Q1 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-159KClosed |
$355K - $758K
|
0
$0
|
|
|
May 13, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-508K- 88.25% |
$1.13M - $2.42M
|
67.7K
$2.03K
|
|
|
May 13, 2022
Q1 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-625K- 43.01% |
$1.39M - $2.98M
|
829K
$24.9K
|